Browse by Tags
All Tags » SmartBrief (RSS)
Sorry, but there are no more tags available to filter with.
-
|
The National Heart, Lung and Blood Institute in February released the first U.S. clinical guidelines for von Willebrand disease, a bleeding disorder due to a deficiency in a blood protein needed for normal clotting. The guidelines are aimed at advancing...
|
-
|
The FDA issued a rule that limits revisions made by drug and medical-device makers to product warnings. The measure may protect companies from patients' lawsuits by enabling them to claim "complete immunity" for failing to warn about potential...
|
-
|
Biotest Diagnostics has received FDA clearance to sell its complete line of traditional blood-bank reagents. The products, which can screen and type blood, are used in matching patients with blood donors, the company said. FDAnews (08/19) Read More.....
|
-
|
Shares in medical device maker Chad Therapeutics Inc. soared more than 60 percent Wednesday after the Chatsworth company said it received clearance from the FDA to market its proprietary sleep disorder diagnostic system. Read More...
|
-
|
Some expectant parents have to decide whether to preserve their children's umbilical-cord blood in private cord blood banks or in public registries seeking to increase donations to spur research. Private firms argue that they provide parents with...
|
-
|
New technology is allowing the Inland Northwest Blood Center in Republic, Wash., to draw two units of blood from donors in a single visit. The LifeSaver 3 is able to draw twice as many red blood cells from donors while returning platelets and plasma,...
|
-
|
The FDA's Center for Devices and Radiological Health needs significant resources to shore up its dwindling expertise in medical devices to better detect problems in the field, an agency director said. "There will be additional activity in the...
|
-
|
Researchers who conducted 123 tests to assess the effects of radio-frequency identification tags on 41 medical devices found that they caused 34 cases of electromagnetic interference, with 22 deemed hazardous. The findings suggest that hospitals should...
|
-
|
Patients are often surprised at the cost of blood, Dessie Baxter of United Blood Services says. Storage, transportation and handling of the blood, as well as the extensive testing to ensure the blood supply is safe, all contribute to the costs, Baxter...
|
-
|
Private-equity firm. acquired GTI Diagnostics, a maker of 20 medical test kits for organ transplant, blood bank and coagulation labs worldwide. Terms of the deal were not disclosed. Plain Dealer (Cleveland), The (07/07) Read More...
|
-
|
AdvaMed SmartBrief | 07/09/2008 Read More...
|
-
|
Artes Medical, Inc. (Nasdaq: ARTE), a medical technology company whose product ArteFill® is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of “smile line” wrinkles, today reported financial results for the three...
|
-
|
Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill® is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial folds also known as “smile line” wrinkles, today reported...
|
-
|
Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill® is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial fold or “smile line” wrinkles, announced that Michael K...
|
-
|
Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill® is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of “smile line” wrinkles, today reported recent company highlights and...
|
|
|
|